The long-term safety of danazol in women with hereditary angioedema
- 1 July 1990
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 54 (1), 64-72
- https://doi.org/10.1016/s0015-0282(16)53638-3
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Danazol for the Treatment of Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1983
- Danazol Increases Factor VIII and Factor IX in Classic Hemophilia and Christmas DiseaseNew England Journal of Medicine, 1983
- Danazol-induced Augmentation of Serum α1-Antitrypsin Levels in Individuals with Marked Deficiency of this AntiproteaseJCI Insight, 1980
- Danazol Suppresses Luteal Function in Vitro and in VivoFertility and Sterility, 1980
- Danazol Binding to Rat Androgen, Glucocorticoid, Progesterone, and Estrogen Receptors: Correlation With Biologic ActivityFertility and Sterility, 1979
- THE EFFECT OF DANAZOL ON MENORRHAGIA, COAGULATION MECHANISMS, HAEMATOLOGICAL INDICES AND BODY WEIGHTBJOG: An International Journal of Obstetrics and Gynaecology, 1979
- The use of an impeded androgen—danazol—in the management of benign breast disordersAmerican Journal of Obstetrics and Gynecology, 1977
- Treatment of Hereditary Angioedema with DanazolNew England Journal of Medicine, 1976
- Clinical Studies with an Antigonadotropin-DanazolFertility and Sterility, 1971
- Steroidal Heterocycles. VII.1 Androstano[2,3-d]isoxazoles and Related CompoundsJournal of Medicinal Chemistry, 1963